Table 2.

Biomarkers for serious condition by 30-day mortality

		Total N = 414						Serious condition Present n = 63						Serious condition Not present n = 351
		Alive n = 397			Deceased n = 17			Alive n = 57			Deceased n = 6			Alive n = 340			Deceased n = 11
		n	Md (IQR)	(%)	n	Md (IQR)	(%)	n	Md (IQR)	(%)	n	Md (IQR)	(%)	n	Md (IQR)	(%)	n	Md (IQR)	(%)
suPAR	ng/ml	4.8 (3.5–6.6)			10.7 (5.8–13.3)			5.4 (4.4–7.4)			12.5 (5.8–15.2)			4.7 (3.5–6.6)			10.3 (4.5–12.7)
suPAR	0–3.9	56		(14.1)	0		(0.0)	1		(1.8)	0		(0)	55		(16.2)	0		(0.0)
	4.0–5.9	211		(53.1)	5		(29.4)	33		(57.9)	2		(33.3)	178		(52.4)	3		(27.3)
	6.0–8.9	80		(20.2)	2		(11.8)	14		(24.6)	0		(0)	66		(19.4)	2		(18.2)
	≥9	50		(12.6)	10		(58.8)	9		(15.8)	4		(66.7)	41		(12.1)	6		(54.5)
Lactate	mmol/l	1.7 (1.3–2.3)			1.8 (1.7–3.3)			1.6 (1.3–2.0)			1.8 (1.7–2.0)			1.7 (1.3–2.4)			2.8 (1.6–4.9)
Lactate	≤2.2	288		(72.5)	10		(63.6)	45		(78.9)	5		(83.3)	243		(71.5)	5		(45.5)
	≥2.3	109		(27.5)	7		(36.4)	12		(21.1)	1		(16.7)	97		(28.5)	6		(54.5)

suPAR: soluble urokinase plasminogen activator receptor